Filana Therapeutics, Inc. FLNA
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 60.20% | 65.67% | -7.02% | -273.73% | -500.27% |
| Total Depreciation and Amortization | 28.35% | 2.93% | -7.88% | -17.31% | -32.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.85% | -15.32% | 140.09% | 121.31% | 120.89% |
| Change in Net Operating Assets | -399.12% | -202.21% | 235.15% | 2,191.02% | -95.64% |
| Cash from Operations | 65.89% | 70.05% | 72.70% | 72.42% | -7.42% |
| Capital Expenditure | -303.65% | -713.51% | -464.08% | -464.08% | -57.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -303.65% | -713.51% | -464.08% | -464.08% | -57.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 60.42% | -100.00% | -100.00% | -99.93% | -99.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 27.78% | -139.29% | -100.37% | -100.19% | -99.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 66.42% | 68.71% | -349.57% | -544.64% | -277.79% |